StockClub

PBIGF

PBIGFParadigm Biopharmaceuticals Limited$ --
Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited

PBIGF

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2026 Q2
Revenue
0M AUD
YoY +50.5%
Operating Income
-22M AUD
YoY -243.8%
Net Income
-23M AUD
YoY -292.2%
EPS
-0.06AUD
YoY -236.5%

Revenue

AUD25,139
FY2022 Q4AUD79,224
AUD79,224
Q4
FY2023 Q2AUD4,710
AUD4,710
Q2
FY2023 Q4AUD46,760
AUD46,760
Q4
FY2024 Q2AUD0
AUD0
Q2
FY2024 Q4AUD65,800
AUD65,800
Q4
FY2025 Q2AUD16,700
AUD16,700
Q2
FY2025 Q4AUD52,120
AUD52,120
Q4
FY2026 Q2AUD25,139
AUD25,139
Q2
Actual
+AUD8,439 (+50.5%)

Net Income

AUD-23.2M
FY2022 Q4AUD-39.3M
AUD-39.3M
Q4
FY2023 Q2AUD-31.9M
AUD-31.9M
Q2
FY2023 Q4AUD-51.9M
AUD-51.9M
Q4
FY2024 Q2AUD-49M
AUD-49M
Q2
FY2024 Q4AUD-58.7M
AUD-58.7M
Q4
FY2025 Q2AUD-5.9M
AUD-5.9M
Q2
FY2025 Q4AUD-18.8M
AUD-18.8M
Q4
FY2026 Q2AUD-23.2M
AUD-23.2M
Q2
Actual
AUD-17.3M (-292.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:AUD0
Est:AUD2.6M
FY2020MISS
AUD0
FY2021MISS
Actual:AUD20,550
Est:AUD3.4M
FY2021MISS
AUD20,550
FY2022MISS
Actual:AUD79,224
Est:AUD5M
FY2022MISS
AUD79,224
FY2023MISS
Actual:AUD0
Est:AUD9M
FY2023MISS
AUD0
FY2024
Actual:AUD65,800
FY2024
AUD65,800
FY2025MISS
Actual:AUD52,120
Est:AUD1.5M
FY2025MISS
AUD52,120

Analyst Estimates